Previous 10 | Next 10 |
Investing In Cannabis Stocks Long Term In June Are you looking for ways to invest in marijuana stocks for the long term? In 2021 top cannabis stocks offer investors exposure to one of the fastest-growing markets in the world. In the next five years, cannabis sales are predicted to m...
Roche (RHHBY) unit Genentech announces the latest data from Phase III studies of Venclexta (venetoclax), developed in collaboration with AbbVie (ABBV) in chronic lymphocytic leukemia ((CLL)) and acute myeloid leukemia ((AML)). In Phase III CLL14 study after a median f...
New Data Shows AbbVie's VENCLYXTO®/VENCLEXTA® Fixed Duration Combination Demonstrates Sustained Progression-Free Survival in Chronic Lymphocytic Leukemia Patients after Three Years off Treatment - Four-year follow-up analysis of Phase 3 CLL14 trial (median follow-up 52...
During May, I made 13 purchases and 0 sales. My passive income was up 17.2% y/y during May 2021. I initiated exposure to Philip Morris and Northrop Grumman last month. For further details see: Nicholas Ward's Dividend Growth Portfolio: May 2021 Review
APTO is presenting new data at EHA21 for its Btk inhibitor, Luxeptinib. The data could be a catalyst event (up or down) for this stock. There's a lot of competition for non-covalent Btk inhibitors in blood cancers. For further details see: Aptose: Cancer Trial Catalyst A...
Dividend Income is the fruit from the labor of investing your money in the stock market. Despite the pandemic from COVID-19, dividend income continues to grow, due primarily to additional investment and reinvestment. In total, dividend increases created a total of $54.26 in additi...
Are you ready for the next market crash? You had better be because the next one is always just around the corner. Short-term minded investors tend to dump their stocks at the first sign of a market crash and it's a surefire way to underperform over the long run. Successful investors, th...
The Vanguard Total Stock Market ETF is a good choice for investors looking for broad market exposure and is our family’s largest single stock asset holding. It offers a low cost and highly liquid approach to gain market exposure and diversification over the entire market spectr...
Kiplinger Investing publishes opportune buy lists for investors on-line. Two billionaires stock lists are here: first, 50 published 12/8/20, was seconded by 30 more June 1, 2021. Seventeen were duplicated, leaving 63. 41 of these 63 billionaire-held stocks pay dividends. As of 6/7/21 ...
Thanks to exchange-traded funds (ETFs), investors don’t have to be tied to one specific stock. Biotech ETFs allow market participants to invest in multiple biotech companies via one vehicle. The life science sector certainly holds a risk factor, and ETFs are a good wa...
News, Short Squeeze, Breakout and More Instantly...
2024-05-20 10:58:01 ET Wall Street is feeling pretty good about AbbVie 's (NYSE: ABBV) performance in 2024 so far. Louise Chen from Cantor Fitzgerald recently initiated coverage on the stock with an overweight rating. Chen also slapped a $200 price target on the pharma stock, ...
President Joe Biden's administration is moving to reschedule cannabis from Schedule I to Schedule III under the Controlled Substances Act (CSA)...
Cantor Fitzgerald has initiated coverage on AbbVie Inc (NYSE:ABBV), a global pharma company. The analyst notes that the company has ...